Pooh payment
AstraZeneca have announced that, as the WuFlu changes from pandemic to endemic—their words, not mine—the company will start to make some profit from its Chongvax. Nick Dearden, director of campaign group Global Justice Now, who appears to live in an economic fantasy land, railed against the decision, stating that it shows the utter folly of giving away publicly-funded science to big pharma
. While the AZ vaccine was developed in conjunction with Oxford University, the company has borne the cost of production and getting the drug to market. And it's still the cheapest on the market.
Perhaps Dearden could do something more constructive instead, and persuade China to do the decent thing by footing the bill for their pestilence. After all, China's Sinovac is one of the more expensive Chongvaxes on the market. Along with the global sales of Chongmasks, it must be contributing healthily to President Pooh's economic resurgence.
Good luck with that, dipshit!* (rolleyes)
* That's Nick Dearden, not you gentle reader. Unless you are he; in which case, YOU!